Results 1 to 10 of about 1,287,782 (264)

Drug resistance in Plasmodium [PDF]

open access: yesNature Reviews Microbiology, 2018
A marked decrease in malaria-related deaths worldwide has been attributed to the administration of effective antimalarials against Plasmodium falciparum, in particular, artemisinin-based combination therapies (ACTs). Increasingly, ACTs are also used to treat Plasmodium vivax, the second major human malaria parasite.
Kasturi Haldar   +2 more
exaly   +3 more sources

Drug resistance [PDF]

open access: yesInternational Journal of Oncology, 1996
An overview of the current mechanisms identified as associated with the expression of multidrug resistance is provided. The clinical relevance of multidrug resistance associated with the overexpression of the three major drug resistance-associated proteins namely, P-glycoprotein, MRP and/or LRP, is discussed.
Giaccone, G., Pinedo, H.M.
openaire   +5 more sources

Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study

open access: yesMicrobiology Spectrum, 2023
With the application of bedaquiline (Bdq), the success rate of multidrug-resistant tuberculosis (MDR-TB) treatment has been significantly improved; however, the cardiac safety of the patients during treatment cannot be ignored. Hence, this study compared
Rong Li   +6 more
doaj   +1 more source

Introduction: Drug Resistance [PDF]

open access: yesChemical Reviews, 2021
Neşe Kurt Yilmaz, Celia A Schiffer
exaly   +3 more sources

A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections

open access: yesVaccines, 2023
Antibody Dependent Enhancement (ADE) of an infection has been of interest in the investigation of many viruses. It is associated with the severity of the infection.
Jyoti Sawant, Ajit Patil, Swarali Kurle
doaj   +1 more source

Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis

open access: yesBMC Infectious Diseases, 2023
Background The World Health Organization has reported that the treatment success rate of multi-drug resistance tuberculosis is approximately 57% globally. Although new drugs such as bedaquiline and linezolid is likely improve the treatment outcome, there
J-B Ma   +9 more
doaj   +1 more source

Experimental Closed-Loop Control of Breast Cancer in Mice

open access: yesComplexity, 2022
Cancer therapy optimization is an issue that can be solved using the control engineering approach. An optimal therapy generation algorithm is presented and tested using a tractable mouse model of breast cancer.
Levente Kovács   +7 more
doaj   +1 more source

Structure-Aware Mycobacterium tuberculosis Functional Annotation Uncloaks Resistance, Metabolic, and Virulence Genes

open access: yesmSystems, 2021
Accurate and timely functional genome annotation is essential for translating basic pathogen research into clinically impactful advances. Here, through literature curation and structure-function inference, we systematically update the functional genome ...
Samuel J. Modlin   +10 more
doaj   +1 more source

Burden of malaria infection among individuals of varied blood groups in Kenya

open access: yesMalaria Journal, 2022
Background The ABO blood groups consist of A, B, and H carbohydrate antigens, which regulate protein activities during malaria infection in humans.
Redemptah Yeda   +17 more
doaj   +1 more source

Drug Resistance in Leishmaniasis [PDF]

open access: yesJournal of Global Infectious Diseases, 2010
The treatment options of leishmaniasis are limited and far from satisfactory. For more than 60 years, treatment of leishmaniasis has centered around pentavalent antimonials (Sb(v)). Widespread misuse has led to the emergence of Sb(v) resistance in the hyperendemic areas of North Bihar. Other antileishmanials could also face the same fate, especially in
Jaya Chakravarty, Shyam Sundar
openaire   +3 more sources

Home - About - Disclaimer - Privacy